Skip to content
DataLookout
Menu

BRACE-AFibNCT07904507

A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation

StatusNot Yet Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Interventions modified
    • Secondary endpoints: details revised at 3 of 4 entries
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Atrial-Fibrillation-related Quality of Life
Timeframe: From baseline to 3 months

Secondary (4)

NT-proBNP
6-minute walking test (6MWT) distance
Peak flow measurement
Hierarchical composite endpoint comprising

Arms and interventions

DiltiazemExperimental

133 patients are randomized to the experimental intervention and treated with the non-dihydropyridine calcium channel blocker (NDCC) Diltiazem.

BisoprololActive comparator

133 patients are randomized to the control arm and treated with the beta-blocker Bisoprolol.

Drugs: Diltiazem, Bisoprolol

Sites

1 site in 1 country

  • University Hospital BaselBasel, Canton of Basel-City, Switzerland